KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to -$756.0 million.

  • Elevance Health's Change in Receivables fell 49170.98% to -$756.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.5 billion, marking a year-over-year increase of 26983.89%. This contributed to the annual value of $2.5 billion for FY2025, which is 26983.89% up from last year.
  • According to the latest figures from Q4 2025, Elevance Health's Change in Receivables is -$756.0 million, which was down 49170.98% from -$815.0 million recorded in Q3 2025.
  • In the past 5 years, Elevance Health's Change in Receivables ranged from a high of $3.2 billion in Q1 2025 and a low of -$851.0 million during Q3 2024
  • In the last 5 years, Elevance Health's Change in Receivables had a median value of $328.0 million in 2021 and averaged $481.0 million.
  • In the last 5 years, Elevance Health's Change in Receivables soared by 257500.0% in 2023 and then crashed by 49170.98% in 2025.
  • Over the past 5 years, Elevance Health's Change in Receivables (Quarter) stood at $387.0 million in 2021, then soared by 373.39% to $1.8 billion in 2022, then plummeted by 43.5% to $1.0 billion in 2023, then crashed by 81.35% to $193.0 million in 2024, then crashed by 491.71% to -$756.0 million in 2025.
  • Its Change in Receivables stands at -$756.0 million for Q4 2025, versus -$815.0 million for Q3 2025 and $923.0 million for Q2 2025.